Progesterone is often discussed in the context of fertility and pregnancy — but its relationship with sleep is a compelling and often overlooked dimension of this multifaceted hormone. For women over 35, understanding what research shows about progesterone’s role in sleep regulation may provide useful context for some of the sleep changes that can emerge during the perimenopausal transition and pregnancy.
Research suggests that progesterone and its metabolites have direct effects on the central nervous system, including interactions with GABA receptors — the same receptors targeted by certain sleep medications. According to findings referenced by the Mayo Clinic and other medical institutions, progesterone’s neurologically active metabolites may have sedative and anxiolytic properties, which is thought to be one reason why high-progesterone states — like the second half of the menstrual cycle and pregnancy — are sometimes associated with increased sleepiness.
What Progesterone Does in the Brain
Progesterone is converted in the body to allopregnanolone, a neurosteroid that acts as a positive allosteric modulator of GABA-A receptors. GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the brain — it reduces neuronal excitability and promotes relaxation and sleep. By enhancing GABAergic signaling, allopregnanolone may contribute to the sedating effects associated with high progesterone states.
Progesterone Across the Menstrual Cycle
Progesterone levels fluctuate predictably across the menstrual cycle. Following ovulation, the corpus luteum produces a sustained rise in progesterone during the luteal phase (roughly the second half of the cycle). Research suggests this hormonal shift may account for the increased sleepiness and longer sleep duration some women notice in the second half of their cycle, as well as the disrupted sleep and insomnia some experience in the premenstrual phase — when progesterone drops abruptly before menstruation begins.
Progesterone Changes During Perimenopause and Their Sleep Effects
For women in the perimenopausal transition, progesterone levels often begin declining before estrogen does. Research suggests that this early decline in progesterone — which removes its GABA-enhancing, sleep-supportive properties — may partly explain why sleep problems often begin in perimenopause before estrogen levels drop substantially.
This progesterone-first decline theory has interesting implications: some women may notice sleep changes in the context of relatively preserved estrogen levels, and those changes may be related to the loss of progesterone’s neurologically sedating effects rather than estrogen changes alone. Understanding this distinction is clinically relevant because treatments that target estrogen may not fully address sleep issues related to progesterone loss. For a broader overview of perimenopausal sleep changes, see our article on sleep changes in perimenopause.
Progesterone in Pregnancy and Its Sleep Effects
During pregnancy — particularly in the first trimester — progesterone levels rise dramatically and may contribute to the intense fatigue and sleepiness many pregnant women experience. Research suggests this progesterone-driven sleepiness may serve a physiological purpose, supporting rest during a critical period of fetal development.
As pregnancy progresses, however, sleep often becomes more disrupted despite continued high progesterone levels, as physical discomfort, frequent urination, and other factors override the sleep-promoting effects of hormones. After delivery, the abrupt drop in progesterone (along with estrogen) is thought to contribute to mood and sleep disruptions in the postpartum period, as the brain loses both the neurologically active metabolites of progesterone and the GABAergic support they provided. For more on postpartum hormonal changes, see our article on postpartum hormonal changes after 35.
What the Research on Progesterone and Sleep Treatment Shows
Some research has investigated whether progesterone — in bioidentical or synthetic forms — may help address sleep difficulties in perimenopausal and postmenopausal women. Results have been mixed, and the evidence base is not yet robust enough to support broad recommendations. Importantly, different forms of progesterone (bioidentical oral micronized progesterone vs. synthetic progestins) have different properties and may have different effects on sleep and other outcomes.
Oral Micronized Progesterone
Some research suggests that oral micronized progesterone (OMP) — a form of bioidentical progesterone — may have more direct sleep-promoting effects due to higher conversion to allopregnanolone compared to synthetic progestins. A few small studies have found improvements in sleep quality measures in perimenopausal women using OMP. However, the overall evidence base is preliminary, and using any form of hormone therapy involves individual benefit-risk assessment with a healthcare provider. These options are not appropriate for all women and are not indicated during pregnancy.
Factors That Interact With Progesterone and Sleep
Sleep is influenced by many factors simultaneously — it’s rarely one hormone doing one thing. While progesterone may play a meaningful role in sleep regulation, sleep disruptions after 35 often reflect the combined effects of estrogen changes, lifestyle factors, stress, aging-related changes in sleep architecture, and individual variation. Research suggests that a holistic approach to sleep — addressing sleep hygiene, managing stress, and treating any identified medical contributors — alongside any hormonal considerations is likely to be most effective.
If you’re experiencing significant sleep changes, tracking your symptoms over several weeks and bringing them to a healthcare provider can help differentiate between hormonal, behavioral, and structural contributors. Our overview of why sleep changes after 35 provides additional context on the multiple factors involved.
Frequently Asked Questions
Why do I sleep so much in early pregnancy?
The intense fatigue and increased sleep drive common in early pregnancy are thought to be related, at least in part, to the dramatic rise in progesterone and its neurologically active metabolites. Additionally, the physiological demands of early fetal development and the body’s adaptation to pregnancy contribute to increased need for rest. This typically moderates in the second trimester for many women.
Can low progesterone cause insomnia?
Research suggests a plausible relationship between declining progesterone and sleep disruption, particularly in the perimenopausal transition and in the premenstrual phase of the cycle. However, insomnia has multiple possible causes, and low progesterone is rarely the sole factor. A healthcare provider can assess whether hormonal changes may be contributing to your specific sleep pattern.
Should I ask my doctor about progesterone for sleep?
If you’re experiencing significant sleep difficulties in the context of perimenopause or menopause, discussing the full range of options — including hormonal and non-hormonal approaches — with a healthcare provider or menopause specialist is reasonable. Any hormone therapy decision involves comprehensive individual health assessment, and the evidence for progesterone specifically for sleep is still emerging.
Does progesterone cream help with sleep?
Topical progesterone creams are available over-the-counter, but research suggests their absorption and conversion to neurologically active metabolites differs substantially from oral forms. The evidence base for over-the-counter progesterone creams is limited. Using any hormonal product, even over-the-counter, warrants discussion with a healthcare provider.
Key Takeaways
- Progesterone’s metabolite allopregnanolone enhances GABAergic signaling and may have sleep-promoting properties
- In perimenopause, progesterone often declines before estrogen — which may partially explain early sleep changes in the transition
- Early pregnancy is associated with high progesterone and increased sleepiness; the postpartum drop in progesterone may contribute to sleep and mood disruptions
- Research on progesterone therapy for sleep is preliminary; oral micronized progesterone has shown some promise in small studies
- Sleep after 35 is shaped by multiple interacting factors; a comprehensive evaluation with a healthcare provider can identify the most relevant contributors
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.